Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > warrants Aug 22
View:
Post by DJDawg on Aug 19, 2024 10:14am

warrants Aug 22

Found this on stockwatch

----

Theralase Technologies warrants to expire Aug. 22

2024-08-14 18:06 ET - Warrants Expire

Effective at the opening, Aug. 22, 2024, the share purchase warrants of the company will trade for cash on a same-day settlement. The warrants will expire Aug. 22, 2024, and will therefore be halted at 12 p.m. ET and delisted at the close of business on Aug. 22, 2024.

Trade and settlement dates:  trades on Aug. 22, 2024, to settle Aug. 22, 2024

The above is in compliance with trading Rule C.2.18, Expiry Date. Trading in the warrants shall be for cash same-day settlement on the expiry date. On the expiry date, trading shall cease at 12 p.m. ET and no transactions shall take place thereafter except with permission of the exchange.

Comment by Lesalpes29 on Aug 19, 2024 10:29am
Reculer pour mieux sauter! I hope, a lost of 4k$ on my side. GL
Comment by 3Crows on Aug 19, 2024 10:57am
On espre.
Comment by 3Crows on Aug 19, 2024 10:58am
On espre. (Can't edit posts.)
Comment by 3Crows on Aug 19, 2024 10:59am
Sorry, everyone. Please ignore. Clearly this board can not write in French or use accents. I was trying to respond to Lesalpes29 by saying, "We can hope".
Comment by steamfitter on Aug 19, 2024 10:58am
Warrents  were they the ones that could be extended for a further two years 
Comment by DJDawg on Aug 19, 2024 12:07pm
Several people have said that tradeable warrants in this situation cannot be extended. When I looked up the real issue seems to be that no warrants can be extended past 5 yrs. so when other ones are extended is is because they are 2 yr warrants from some of the private placements. Those can be bumped but never past 5 yrs. So not sure about status of warrant expiring in Sept in terms of the 5 yr ...more  
Comment by Mikee3003 on Aug 19, 2024 12:38pm
Dawg - your theory on the warrants is certainly plausible. Could make for an interesting September? GLTA Mikee
Comment by Alamir1111 on Aug 19, 2024 1:13pm
Sept 2022 they issued 10.000.000 units at .25c. Exercisable at.35c
Comment by N0taP00p on Aug 19, 2024 1:32pm
My gut says they will have some kind of announcement around pre-BTD and/or another form of debt financing on the 21st, as a last ditch attempt to get some of those warrants exercised.  Very long shot. Bonus marks if they say pre-BTD has been accepted.  There will be a lot of unhappy investors on the 22nd if they expire worthless. 
Comment by BlueFranky on Aug 19, 2024 4:58pm
DJDawg... I've been pondering on that same theory  ... Wondering which would be worse for the new investor(s) with 10 million to spend:  A) Looking at the delution created by 60 million warrants being exercised?  .. or gaining in the long term benefit those 20 million exercised warrants would have brought to the coffers, no doubt resulting in being the catalyst for future ...more  
Comment by BlueFranky on Aug 19, 2024 5:05pm
Geez I wish you could edit here! My last paragraph should read:  "or gaining by the 20 million, those exercised warrants would have brought to the coffers, no doubt resulting in being a rather immediate catalyst for future trials, among other things ..we'll find out soon enough"
Comment by DJDawg on Aug 19, 2024 5:15pm
Agreed. We will find out soon enough. By mid Sept is my guess. IF the second tranche is exercized at 5m or more then the price would shoot up as no more PPs every 2months. I really believe that creates a huge weight on the share price as you can see the big share dumps whenever a PP is "suspected" and even more when "confirmed".
Comment by enriquesuave on Aug 19, 2024 5:32pm
Having the warrants excercised would be more beneficial, as it would bring in 20$ Million in cash at 35 cents and not 22 or 18 cents a share.  But if they don't get excercised then $5 million from one big investor would definitely also be welcome.  Cash from whatever source will allow the company to proceed on multiple fronts.  
Comment by 2b7f6fab on Aug 19, 2024 3:16pm
I tend to agree with your theory about waiting for the warrants to expire this week before any large investors want in. I believe there is interest in Theralase from large investors.  However considering the small market cap I don't think mgmt wants to lose control of the company.  $5 million investment at 20 cents is 25 million shares.  Much more than insiders have right now.& ...more  
Comment by DJDawg on Aug 19, 2024 3:47pm
If a large investor went in for 5m they would be a big shareholder but not a majority holder so not sure if RDW could lose the company control that easily. Seems like if you want the cash you need to give up something?
Comment by riverrrow on Aug 19, 2024 4:13pm
Waiting to fill a second tranche until after the tradeable warrants expire is not a nice way to treat the little guys supporting TLT.  I'm holding over a million warrants at over 10 cents a warrant average cost.  Five years ago the leverage the warrants provided on the blue sky potential of Ruvidar was astronomical.  
Comment by DJDawg on Aug 19, 2024 4:34pm
I doubt that is what RDW ever wanted. Getting 0.35 a warrant is better but if there is a new arrival investor out there it would be the smart thing to to do for them. Wait out the warrant expiration.
Comment by 2b7f6fab on Aug 19, 2024 6:36pm
I seriously doubt RW is waiting for the warrants to expire before filling a second tranche.  More likely if there is some big money interests they are the ones dictating the terms of when they will offer the money.  Naturally they would want to wait till after the warrants expire. I understand it is discouraging that the warrant holders lose an opportunity but the timing of btd isn't ...more  
Comment by CAinPlap on Aug 20, 2024 2:33am
If there is a $10 million minimum investment entity considering TLT, they will not fill a 2nd tranch of the last PP. They would force TLT into a new PP at better terms. Last PP was overpriced IMO.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250